Certain New Chemicals or Significant New Uses; Statements of Findings for December 2023, 12836-12837 [2024-03364]
Download as PDF
12836
Federal Register / Vol. 89, No. 34 / Tuesday, February 20, 2024 / Notices
the regional water quality control boards
and the State Department of Toxic
Substances Control to control the
mobilization of contaminants and
mitigate impacts.
Decision
The continued operation of LLNL is
critical to NNSA’s Stockpile
Stewardship and Management Program,
to prevent the spread and use of nuclear
weapons worldwide, and to many other
areas that may impact national security
and global stability. NNSA has decided
to implement the Proposed Action. The
Proposed Action will enable NNSA to
fulfill its statutory missions and other
responsibilities, considering economic,
environmental, technical, and other
factors.
Basis for Decision
The Final SWEIS provided the NNSA
decision-maker with important
information regarding the potential
environmental impacts of alternatives
and options for satisfying the purpose
and need. In addition to environmental
information, NNSA also considered
public comments, statutory
responsibilities, strategic objectives,
technical needs, safeguards and
security, costs, and schedule in its
decision-making.
ddrumheller on DSK120RN23PROD with NOTICES1
Mitigation Measures
No potential adverse impacts were
identified that will require additional
mitigation measures beyond those
required by regulations, permits, and
agreements or achieved through design
features or best management practices.
However, if mitigation measures above
and beyond those required by
regulations, permits, and agreements are
needed to reduce impacts during
implementation, they will be developed,
documented, and executed. Because no
new potential adverse impacts were
identified that will require additional
mitigation measures beyond those
required by regulation or achieved
through design features or best
management practices, NNSA does not
expect to prepare a Mitigation Action
Plan.
Signing Authority
This document of the Department of
Energy was signed on February 8, 2024,
by Jill Hruby, Under Secretary for
Nuclear Security and Administrator,
NNSA, pursuant to delegated authority
from the Secretary of Energy. That
document with the original signature
and date is maintained by DOE. For
administrative purposes only, and in
compliance with requirements of the
Office of the Federal Register, the
VerDate Sep<11>2014
16:54 Feb 16, 2024
Jkt 262001
undersigned DOE Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of the Department of
Energy. This administrative process in
no way alters the legal effect of this
document upon publication in the
Federal Register.
Signed in Washington, DC, on February 14,
2024.
Treena V. Garrett,
Federal Register Liaison Officer, U.S.
Department of Energy.
[FR Doc. 2024–03351 Filed 2–16–24; 8:45 am]
BILLING CODE 6450–01–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPPT–2023–0098; FRL–10582–
10–OCSPP]
Certain New Chemicals or Significant
New Uses; Statements of Findings for
December 2023
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Toxic Substances Control
Act (TSCA) requires EPA to publish in
the Federal Register a statement of its
findings after its review of certain TSCA
submissions when EPA makes a finding
that a new chemical substance or
significant new use is not likely to
present an unreasonable risk of injury to
health or the environment. Such
statements apply to premanufacture
notices (PMNs), microbial commercial
activity notices (MCANs), and
significant new use notices (SNUNs)
submitted to EPA under TSCA. This
document presents statements of
findings made by EPA on such
submissions during the period from
December 1, 2023, to December 31,
2023.
ADDRESSES: The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPPT–2023–0098, is
available online at https://
www.regulations.gov or in-person at the
Office of Pollution Prevention and
Toxics Docket (OPPT Docket),
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC.
The Public Reading Room is open from
8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The
telephone number for the Public
Reading Room is (202) 566–1744, and
the telephone number for the OPPT
Docket is (202) 566–0280. For the latest
SUMMARY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
status information on EPA/DC services
and docket access, visit https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Rebecca Edelstein, New Chemical
Division (7405M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: (202) 564–1667
email address: edelstein.rebecca@
epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
I. Executive Summary
A. Does this action apply to me?
This action provides information that
is directed to the public in general.
B. What action is the Agency taking?
This document lists the statements of
findings made by EPA after review of
submissions under TSCA section 5(a)
that certain new chemical substances or
significant new uses are not likely to
present an unreasonable risk of injury to
health or the environment. This
document presents statements of
findings made by EPA during the
reporting period.
C. What is the Agency’s authority for
taking this action?
TSCA section 5(a)(3) requires EPA to
review a submission under TSCA
section 5(a) and make one of several
specific findings pertaining to whether
the substance may present unreasonable
risk of injury to health or the
environment. Among those potential
findings is that the chemical substance
or significant new use is not likely to
present an unreasonable risk of injury to
health or the environment per TSCA
section 5(a)(3)(C).
TSCA section 5(g) requires EPA to
publish in the Federal Register a
statement of its findings after its review
of a submission under TSCA section
5(a) when EPA makes a finding that a
new chemical substance or significant
new use is not likely to present an
unreasonable risk of injury to health or
the environment. Such statements apply
to PMNs, MCANs, and SNUNs
submitted to EPA under TSCA section
5.
Anyone who plans to manufacture
(which includes import) a new chemical
substance for a non-exempt commercial
purpose and any manufacturer or
E:\FR\FM\20FEN1.SGM
20FEN1
Federal Register / Vol. 89, No. 34 / Tuesday, February 20, 2024 / Notices
processor wishing to engage in a use of
a chemical substance designated by EPA
as a significant new use must submit a
notice to EPA at least 90 days before
commencing manufacture of the new
chemical substance or before engaging
in the significant new use.
The submitter of a notice to EPA for
which EPA has made a finding of ‘‘not
likely to present an unreasonable risk of
injury to health or the environment’’
may commence manufacture of the
chemical substance or manufacture or
processing for the significant new use
notwithstanding any remaining portion
of the applicable review period.
D. Does this action have any
incremental economic impacts or
paperwork burdens?
No.
ddrumheller on DSK120RN23PROD with NOTICES1
II. Statements of Findings Under TSCA
Section 5(a)(3)(C)
In this unit, EPA provides the
following information (to the extent that
such information is not claimed as
Confidential Business Information
(CBI)) on the PMNs, MCANs, and
SNUNs for which, during this period,
EPA has made findings under TSCA
section 5(a)(3)(C) that the new chemical
substances or significant new uses are
not likely to present an unreasonable
risk of injury to health or the
environment:
The following list provides the EPA
case number assigned to the TSCA
section 5(a) submission and the
chemical identity (generic name if the
specific name is claimed as CBI).
• P–23–0017, Hydrolyzed collagen,
polymer with aromatic isocyanate, Ntriethoxysylil-alkanamine, pectic
polysaccharide and poly alkyl alcohol
(Generic Name).
• P–23–0068, 1,3Isobenzofurandione, hexahydro-,
polymer with 1,4cyclohexanedimethanol, isononanoate
(CASRN 2773548–84–6).
To access EPA’s decision document
describing the basis of the ‘‘not likely to
present an unreasonable risk’’ finding
made by EPA under TSCA section
5(a)(3)(C), look up the specific case
number at https://www.epa.gov/
reviewing-new-chemicals-under-toxicsubstances-control-act-tsca/chemicalsdetermined-not-likely.
Authority: 15 U.S.C. 2601 et seq.
Dated: February 13, 2024.
Shari Z. Barash,
Acting Director, New Chemicals Division,
Office of Pollution Prevention and Toxics.
[FR Doc. 2024–03364 Filed 2–16–24; 8:45 am]
BILLING CODE 6560–50–P
VerDate Sep<11>2014
16:54 Feb 16, 2024
Jkt 262001
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OW–2023–0475; FRL 10889–01–
OW]
Draft Guidance for Future National
Pollutant Discharge Elimination
System (NPDES) Permitting of
Combined Sewer Systems
Environmental Protection
Agency (EPA).
ACTION: Notice; request for comment.
AGENCY:
The U.S. Environmental
Protection Agency (EPA) is seeking
comment on this draft Guidance to
clarify and inform future National
Pollutant Discharge Elimination System
(NPDES) permitting actions for
communities with combined sewer
systems. This draft Guidance highlights
the available approaches for permitting
combined sewer overflow (CSO)
communities nearing completion of the
projects and activities identified in their
Long-Term Control Plan (LTCP). The
draft Guidance summarizes options
under the Clean Water Act (CWA) that
are articulated in the 1994 Combined
Sewer Overflow Control Policy and the
option to use the EPA’s 2012 Integrated
Planning Framework to look holistically
at future investments in controlling
wastewater and stormwater discharges
and improving water quality.
DATES: Comments must be received on
or before March 21, 2024.
ADDRESSES: You may send comments,
identified by Docket ID No. EPA–HQ–
OW–2023–0475, by any of the following
methods:
• Federal eRulemaking Portal:
https://www.regulations.gov (our
preferred method). Follow the online
instructions for submitting comments.
• Mail: U.S. Environmental
Protection Agency, EPA Docket Center,
Water Docket, Mail Code 28221T, 1200
Pennsylvania Avenue NW, Washington,
DC 20460.
• Hand Delivery or Courier: EPA
Docket Center, WJC West Building,
Room 3334, 1301 Constitution Avenue
NW, Washington, DC 20004. The Docket
Center’s hours of operations are 8:30
a.m. to 4:30 p.m., Monday through
Friday (except Federal Holidays).
Instructions: All submissions received
must include the Docket ID No. for this
rulemaking. Comments received may be
posted without change to https://
www.regulations.gov, including any
personal information provided. For
detailed instructions on sending
comments, see the ‘‘Public
Participation’’ heading of the
SUPPLEMENTARY INFORMATION section of
this document.
SUMMARY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
12837
FOR FURTHER INFORMATION CONTACT:
Kathryn Kazior, Office of Wastewater
Management, Water Permits Division
(MC4203M), Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460; telephone
number: (202) 564–2696; email address:
kazior.kathryn@epa.gov.
SUPPLEMENTARY INFORMATION:
Supporting Documentation. The docket
contains supporting materials that were
referenced in the development of this
Guidance.
I. Executive Summary
The Combined Sewer Overflow (CSO)
Control Policy (CSO Policy) was issued
in 1994 and incorporated into the Clean
Water Act (CWA) in 2000.1 Since its
issuance, communities with combined
sewer systems nationwide have made
substantial progress toward the goals
established in the CSO Policy. During
this same time, many factors that
influence how communities address
CSOs have evolved. Recognizing these
ongoing changes and to aid
communities addressing multiple
municipal CWA requirements, in 2012,
the EPA developed an Integrated
Planning Framework that clarifies CWA
flexibilities and offers a voluntary
opportunity for a municipality to
prioritize and sequence, where
appropriate, those infrastructure
projects that provide the greatest or
fastest environmental and public health
benefits. Integrated planning was added
to the CWA in 2019.2 The EPA is issuing
this draft Guidance to clarify and inform
future National Pollutant Discharge
Elimination System (NPDES) permitting
actions for communities with CSOs.
This draft Guidance would be
applicable to permitting actions once
the CSO permittee has completed
construction of CSO controls and
demonstrated that they are achieving
the performance objectives outlined in
their Long-Term Control Plan (LTCP).
The draft Guidance is intended to
1 In the Wet Weather Water Quality Act of 2000,
Congress added section 402(q) to the CWA to
provide that each permit, order, or decree issued
after December 21, 2000, for a discharge from a
municipal combined storm and sanitary sewer shall
conform to the 1994 Combined Sewer Overflow
Control Policy (33 U.S.C. 1342(q)(1)).
2 In the Water Infrastructure Improvement Act
(H.R. 7279), Congress added section 402(s) to the
CWA that defines an Integrated Plan as one
developed in accordance with the 2012 Integrated
Municipal Stormwater and Wastewater Planning
Approach Framework; and requires the EPA to
inform municipalities of the opportunity to develop
an Integrated Plan that may inform permit terms
and conditions to help meet their existing CWA
obligations (33 U.S.C. 1342(s)). These amendments
clarified that municipalities may develop an
Integrated Plan as defined under the CWA and the
permitting authority may develop NPDES permit
terms and conditions informed by that plan.
E:\FR\FM\20FEN1.SGM
20FEN1
Agencies
[Federal Register Volume 89, Number 34 (Tuesday, February 20, 2024)]
[Notices]
[Pages 12836-12837]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03364]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2023-0098; FRL-10582-10-OCSPP]
Certain New Chemicals or Significant New Uses; Statements of
Findings for December 2023
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to
publish in the Federal Register a statement of its findings after its
review of certain TSCA submissions when EPA makes a finding that a new
chemical substance or significant new use is not likely to present an
unreasonable risk of injury to health or the environment. Such
statements apply to premanufacture notices (PMNs), microbial commercial
activity notices (MCANs), and significant new use notices (SNUNs)
submitted to EPA under TSCA. This document presents statements of
findings made by EPA on such submissions during the period from
December 1, 2023, to December 31, 2023.
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPPT-2023-0098, is available online
at https://www.regulations.gov or in-person at the Office of Pollution
Prevention and Toxics Docket (OPPT Docket), Environmental Protection
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading
Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday,
excluding legal holidays. The telephone number for the Public Reading
Room is (202) 566-1744, and the telephone number for the OPPT Docket is
(202) 566-0280. For the latest status information on EPA/DC services
and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Rebecca Edelstein, New Chemical
Division (7405M), Office of Pollution Prevention and Toxics,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number: (202) 564-1667 email address:
[email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. Executive Summary
A. Does this action apply to me?
This action provides information that is directed to the public in
general.
B. What action is the Agency taking?
This document lists the statements of findings made by EPA after
review of submissions under TSCA section 5(a) that certain new chemical
substances or significant new uses are not likely to present an
unreasonable risk of injury to health or the environment. This document
presents statements of findings made by EPA during the reporting
period.
C. What is the Agency's authority for taking this action?
TSCA section 5(a)(3) requires EPA to review a submission under TSCA
section 5(a) and make one of several specific findings pertaining to
whether the substance may present unreasonable risk of injury to health
or the environment. Among those potential findings is that the chemical
substance or significant new use is not likely to present an
unreasonable risk of injury to health or the environment per TSCA
section 5(a)(3)(C).
TSCA section 5(g) requires EPA to publish in the Federal Register a
statement of its findings after its review of a submission under TSCA
section 5(a) when EPA makes a finding that a new chemical substance or
significant new use is not likely to present an unreasonable risk of
injury to health or the environment. Such statements apply to PMNs,
MCANs, and SNUNs submitted to EPA under TSCA section 5.
Anyone who plans to manufacture (which includes import) a new
chemical substance for a non-exempt commercial purpose and any
manufacturer or
[[Page 12837]]
processor wishing to engage in a use of a chemical substance designated
by EPA as a significant new use must submit a notice to EPA at least 90
days before commencing manufacture of the new chemical substance or
before engaging in the significant new use.
The submitter of a notice to EPA for which EPA has made a finding
of ``not likely to present an unreasonable risk of injury to health or
the environment'' may commence manufacture of the chemical substance or
manufacture or processing for the significant new use notwithstanding
any remaining portion of the applicable review period.
D. Does this action have any incremental economic impacts or paperwork
burdens?
No.
II. Statements of Findings Under TSCA Section 5(a)(3)(C)
In this unit, EPA provides the following information (to the extent
that such information is not claimed as Confidential Business
Information (CBI)) on the PMNs, MCANs, and SNUNs for which, during this
period, EPA has made findings under TSCA section 5(a)(3)(C) that the
new chemical substances or significant new uses are not likely to
present an unreasonable risk of injury to health or the environment:
The following list provides the EPA case number assigned to the
TSCA section 5(a) submission and the chemical identity (generic name if
the specific name is claimed as CBI).
P-23-0017, Hydrolyzed collagen, polymer with aromatic
isocyanate, N-triethoxysylil-alkanamine, pectic polysaccharide and poly
alkyl alcohol (Generic Name).
P-23-0068, 1,3-Isobenzofurandione, hexahydro-, polymer
with 1,4-cyclohexanedimethanol, isononanoate (CASRN 2773548-84-6).
To access EPA's decision document describing the basis of the ``not
likely to present an unreasonable risk'' finding made by EPA under TSCA
section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/chemicals-determined-not-likely.
Authority: 15 U.S.C. 2601 et seq.
Dated: February 13, 2024.
Shari Z. Barash,
Acting Director, New Chemicals Division, Office of Pollution Prevention
and Toxics.
[FR Doc. 2024-03364 Filed 2-16-24; 8:45 am]
BILLING CODE 6560-50-P